# Expert Review of Clinical Pharmacology

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/expert-review-of-clinical-pharmacology/

## Facts

| Field | Value |
| --- | --- |
| Citations | 39,980 |
| h-index | 82 |
| Homepage | http://informahealthcare.com/journal/erj |
| Open Access | false |
| ISSN-L | 1751-2433 |
| ISSNs | 1751-2433,1751-2441 |
| OpenAlex ID | https://openalex.org/S102962966 |
| Publisher | Taylor & Francis |
| Works | 1,938 |

## Journal papers

- [Brain injury with diabetes mellitus: evidence, mechanisms and treatment implications](https://scholariq.org/papers/brain-injury-with-diabetes-mellitus-evidence-mechanisms-and-treatment/)
- [Neurologic conditions and disorders of uremic syndrome of chronic kidney disease: presentations, causes, and treatment strategies](https://scholariq.org/papers/neurologic-conditions-and-disorders-of-uremic-syndrome-of-chronic-kidney-disease/)
- [Pharmacological Management of Postmenopausal Osteoporosis: a Level I Evidence Based - Expert Opinion](https://scholariq.org/papers/pharmacological-management-of-postmenopausal-osteoporosis-a-level-i-evidence/)
- [LDL-C does not cause cardiovascular disease: a comprehensive review of the current literature](https://scholariq.org/papers/ldl-c-does-not-cause-cardiovascular-disease-a-comprehensive-review-of-the/)
- [Pharmacological treatment of primary membranous nephropathy in 2016](https://scholariq.org/papers/pharmacological-treatment-of-primary-membranous-nephropathy-in-2016/)
- [Cannabidiol drug interaction considerations for prescribers and pharmacists](https://scholariq.org/papers/cannabidiol-drug-interaction-considerations-for-prescribers-and-pharmacists/)
- [Novel and emerging treatment strategies for lupus nephritis](https://scholariq.org/papers/novel-and-emerging-treatment-strategies-for-lupus-nephritis/)
- [Lipid profile changes induced by glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis](https://scholariq.org/papers/lipid-profile-changes-induced-by-glucagon-like-peptide-1-receptor-agonists-in/)
- [The effectiveness of cerebrolysin, a multi-modal neurotrophic factor, for treatment of post-covid-19 persistent olfactory, gustatory and trigeminal chemosensory dysfunctions: a randomized clinical trial](https://scholariq.org/papers/the-effectiveness-of-cerebrolysin-a-multi-modal-neurotrophic-factor-for/)

## Journal top topics

Showing 8 of 25.

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Pharmaceutical studies and practices](https://scholariq.org/topics/pharmaceutical-studies-and-practices/)
- [Pharmacogenetics and Drug Metabolism](https://scholariq.org/topics/pharmacogenetics-and-drug-metabolism/)
- [Pharmacological Effects and Toxicity Studies](https://scholariq.org/topics/pharmacological-effects-and-toxicity-studies/)
- [Pharmaceutical Practices and Patient Outcomes](https://scholariq.org/topics/pharmaceutical-practices-and-patient-outcomes/)
- [Antibiotics Pharmacokinetics and Efficacy](https://scholariq.org/topics/antibiotics-pharmacokinetics-and-efficacy/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.